NKY Pharma

Boai NKY Pharmaceuticals Ltd (NKY, stock code: 300109) was the first domestic company to develop and manufacture polyvinylpyrrolidone (PVP) series products in China. With more than 27 year’s experience in PVP production coupled to a dedicated commitment to quality improvement and management, NKY has become the largest Chinese producer of PVP’s and third largest globally. In April of 2013, construction of NKY’s new plant with 138,800 m2of land and 50,000 m2of structure was completed, making it the production center for our PVP and PVM/MA polymer families. The new facilities includes production capacity of: 12,000 tons/year GBL; 5,000 tons/year 2-pyrrolidone; 5,000 tons/year NVP; 2,500 tons/year PVM/MA copolymer; 2,000 tons/year MVE.